These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2480399)

  • 21. Experimental autoimmune encephalomyelitis in the rat.
    Swanborg RH; Stepaniak JA
    Curr Protoc Immunol; 2001 May; Chapter 15():15.2.1-15.2.14. PubMed ID: 18432734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependency of MBP-induced demyelination in the guinea pig.
    Moore GR; Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1985 Sep; 70(2):197-205. PubMed ID: 2414404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed type skin response to myelin basic protein in chronic relapsing experimental allergic encephalomyelitis.
    Tabira T; Itoyama Y; Kuroiwa Y; Kubo C; Nagai Y
    J Neuroimmunol; 1983 Dec; 5(3):295-304. PubMed ID: 6655050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein.
    Sobel RA; Tuohy VK; Lu ZJ; Laursen RA; Lees MB
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):468-79. PubMed ID: 2273404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The encephalitogenicity of the Hempt vaccine.
    Nyerges G; Jaszovszky S; Pintér A; Hompó Z
    Dev Biol Stand; 1977; 34():165-8. PubMed ID: 838141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
    Stepaniak JA; Gould KE; Sun D; Swanborg RH
    J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of resistance to experimental allergic encephalomyelitis in newborn guinea pigs.
    Staykova M; Kozovska M; Kirazjan N; Goranov I
    Neurol Psychiatr (Bucur); 1989; 27(3):225-9. PubMed ID: 2479972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demyelinating disease: an immunological model for studies of neural antigens.
    Hashim GA
    Gerontology; 1987; 33(3-4):181-6. PubMed ID: 2443426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apoprotein.
    Satoh J; Sakai K; Endoh M; Koike F; Kunishita T; Namikawa T; Yamamura T; Tabira T
    J Immunol; 1987 Jan; 138(1):179-84. PubMed ID: 3491156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative effectiveness of spinal cord and purified myelin basic protein in producing resistance to experimental allergic encephalomyelitis.
    McDermott JR; Keith AB
    Eur Neurol; 1979; 18(2):136-9. PubMed ID: 88369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination.
    Cross AH; Tuohy VK; Raine CS
    Cell Immunol; 1993 Feb; 146(2):261-9. PubMed ID: 7513616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Bitar DM; Whitacre CC
    Cell Immunol; 1988 Apr; 112(2):364-70. PubMed ID: 2451570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
    Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
    Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on demyelinating effect of galactocerebroside in experimental allergic encephalomyelitis.
    Khang SK; Chi JG; Lee SK
    J Korean Med Sci; 1988 Sep; 3(3):89-98. PubMed ID: 2477039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates.
    McKenna RM; Carter BG; Paterson JA; Sehon AH
    Cell Immunol; 1983 Oct; 81(2):391-402. PubMed ID: 6196127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein suppresses experimental allergic encephalomyelitis.
    Abramsky O; Brenner T; Mizrachi R; Soffer D
    J Neuroimmunol; 1982 Jan; 2(1):1-7. PubMed ID: 6185533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.
    Fritz RB; Zhao ML
    J Neurosci Res; 1996 Aug; 45(4):471-4. PubMed ID: 8872908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of acute and chronic experimental allergic encephalomyelitis in Strain 13 guinea pigs. A clinical and pathological study.
    Raine CS; Snyder DH; Stone SH; Bornstein MB
    J Neurol Sci; 1977 Apr; 31(3):355-67. PubMed ID: 845617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.